CRPC w/ Bone Metastases - Results from #200

REVIEW UroToday

Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors May 9, 2016

Effects of Src-kinase inhibition in cancer-induced bone pain April 26, 2016

The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer April 24, 2016

When Men With Advanced Prostate Cancer Aren’t Speaking, Clinicians Must Encourage Talk About Emerging Symptoms - A Conversation with Neal Shore April 20, 2016

Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study April 19, 2016

Avascular Necrosis of the Femoral Head After Palliative Radiotherapy in Metastatic Prostate Cancer: Absence of a Dose Threshold? April 18, 2016

PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer April 17, 2016

Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer April 11, 2016

68Ga-PSMA PET/CT Imaging and 153Sm-EDTMP Bone Pain Palliation Therapy April 10, 2016

Healing Sacral Fracture Masquerading as Metastatic Bone Disease on a 68Ga-PSMA PET/CT April 10, 2016

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer April 6, 2016

JOURNAL CLUB: Identification of Bone Metastasis With Routine Prostate MRI: A Study of Patients With Newly Diagnosed Prostate Cancer April 6, 2016

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA March 29, 2016

Patient-reported quality of life analysis of radium-223 dichloride from the phase 3 ALSYMPCA study February 29, 2016

The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone February 25, 2016

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 February 25, 2016

Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study February 24, 2016

Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer February 22, 2016

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer February 22, 2016

Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy February 22, 2016

Page 11 of 15